What Acetyl Octapeptide-3 is
Acetyl octapeptide-3 is a cosmetic peptide used in topical anti-aging products and often marketed as a stronger expression-line peptide.
Acetyl Octapeptide-3 is grouped under Longevity + Skin on PeptideFactCheck because it appears in the same cosmetic-peptide lane as Argireline and related anti-wrinkle products.
The useful starting point is to separate the molecule itself from the internet story around it. It appears in the same cosmetic-peptide lane as Argireline and related anti-wrinkle products.
Why people keep looking it up
It appears in the same cosmetic-peptide lane as Argireline and related anti-wrinkle products.
Acetyl octapeptide-3 is a cosmetic peptide used in topical anti-aging products and often marketed as a stronger expression-line peptide.
Acetyl Octapeptide-3 tends to stay in the conversation because it touches a familiar public theme: cosmetic peptide, expression-line discussion, and topical skin. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Cosmetic peptide category with mostly anecdotal or marketing-level support.
Most of the evidence sits in cosmetic-product marketing rather than strong therapeutic proof.
Mechanistic claims are usually extrapolated from peptide-cosmetic theory rather than robust clinical programs.
Why this page carries the current tier: Cosmetic peptide category with mostly anecdotal or marketing-level support.
The current seed trail for Acetyl Octapeptide-3 is pulling from 1 literature source, 1 trials source, and 1 databases source.
Safety, limits, and regulatory context
The main issue is marketing inflation, not a clean medical-evidence framework.
This is not tracked here as an FDA-approved peptide drug.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Acetyl Octapeptide-3. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for Acetyl Octapeptide-3 is CID 71587832. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 71587832
- Formula
- C42H72N16O15S
- Molecular weight
- 1073.2
- InChIKey
- QGGBBQJHVCVVKM-XOBYPWAZSA-N
Matched synonyms include Acetyl octapeptide-3, UNII-8K14HJF88S, 8K14HJF88S, Acetyl-glu-glu-met-gln-arg-arg-ala-asp-amide, DTXSID70235943, RefChem:109067, DTXCID00158434, ACETYL OCTAPEPTIDE-3 [INCI].
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for Acetyl Octapeptide-3 returns 0 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
No linked intervention records were returned by the current ClinicalTrials.gov query terms for this page.
Literature snapshot
The current PubMed query for Acetyl Octapeptide-3 returns 2 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Label and regulatory records
For approved or clinically developed peptides, the page now pulls in official labeling and FDA-facing records where they exist. That makes the regulatory section materially more useful than a generic approved or not-approved tag.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.